全文获取类型
收费全文 | 7300篇 |
免费 | 469篇 |
国内免费 | 52篇 |
专业分类
耳鼻咽喉 | 68篇 |
儿科学 | 171篇 |
妇产科学 | 111篇 |
基础医学 | 913篇 |
口腔科学 | 67篇 |
临床医学 | 807篇 |
内科学 | 1933篇 |
皮肤病学 | 101篇 |
神经病学 | 684篇 |
特种医学 | 391篇 |
外科学 | 959篇 |
综合类 | 54篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 399篇 |
眼科学 | 106篇 |
药学 | 465篇 |
中国医学 | 2篇 |
肿瘤学 | 588篇 |
出版年
2023年 | 38篇 |
2022年 | 55篇 |
2021年 | 145篇 |
2020年 | 98篇 |
2019年 | 142篇 |
2018年 | 194篇 |
2017年 | 125篇 |
2016年 | 139篇 |
2015年 | 179篇 |
2014年 | 236篇 |
2013年 | 333篇 |
2012年 | 538篇 |
2011年 | 522篇 |
2010年 | 340篇 |
2009年 | 313篇 |
2008年 | 464篇 |
2007年 | 507篇 |
2006年 | 417篇 |
2005年 | 474篇 |
2004年 | 479篇 |
2003年 | 404篇 |
2002年 | 373篇 |
2001年 | 71篇 |
2000年 | 66篇 |
1999年 | 59篇 |
1998年 | 114篇 |
1997年 | 96篇 |
1996年 | 79篇 |
1995年 | 86篇 |
1994年 | 78篇 |
1993年 | 58篇 |
1992年 | 50篇 |
1991年 | 41篇 |
1990年 | 32篇 |
1989年 | 43篇 |
1988年 | 36篇 |
1987年 | 35篇 |
1986年 | 27篇 |
1985年 | 36篇 |
1984年 | 23篇 |
1983年 | 24篇 |
1982年 | 30篇 |
1981年 | 20篇 |
1980年 | 25篇 |
1978年 | 16篇 |
1977年 | 22篇 |
1976年 | 22篇 |
1974年 | 13篇 |
1973年 | 13篇 |
1971年 | 14篇 |
排序方式: 共有7821条查询结果,搜索用时 15 毫秒
61.
62.
63.
Vincent Moreau BA Gilles Bégin BSc Charles M. Morin PhD 《Residential treatment for children & youth》2013,30(1):21-35
The main objective of this study was to document sleep patterns and disturbances reported by youths temporarily living in residential care facilities. A secondary objective was to examine the relationships between sleep disturbances and mood and daytime sleepiness. A self-reported questionnaire on sleep patterns and habits assessing duration, frequency, and consequences of sleep difficulties, the Beck Depression Inventory-2, and the Epworth Sleepiness Scale were administered to a sample of 66 adolescents. Results suggest a high rate of sleep disturbances in this sample, with 41% reporting insomnia symptoms and 21% meeting diagnostic criteria for an insomnia syndrome. Those with more severe insomnia syndrome showed more severe depressive symptoms and daytime consequences. 相似文献
64.
65.
66.
Molecular analyses of patients with hyperferritinemia and normal serum iron values reveal both L ferritin IRE and 3 new ferroportin (slc11A3) mutations 总被引:9,自引:1,他引:9 下载免费PDF全文
Unexplained hyperferritinemia is a common clinical finding, even in asymptomatic persons. When early onset bilateral cataracts are also present, the hereditary hyperferritinemia-cataract syndrome (HHCS), because of heterozygous point mutation in the L ferritin iron-responsive element (IRE) sequence, can be suspected. We sequenced the L ferritin exon 1 in 52 DNA samples from patients referred to us for molecular diagnosis of HHCS. We identified 24 samples with a point mutation/deletion in the IRE. For the 28 samples in which no IRE mutation was present, we also genotyped HFE mutations and sequenced both H ferritin and ferroportin genes. We found an increased frequency of His63Asp heterozygotes (12 of 28) but no H ferritin mutations. We identified 3 new ferroportin mutations, producing, respectively, Asp157Gly, Gln182His, and Gly323Val amino acid replacements, suggesting that these patients have dominant type 4 hemochromatosis. This study demonstrates that both L ferritin IRE and ferroportin mutations can account for isolated hyperferritinemia. The presence of cataract does not permit the unambiguous identification of patients with HHCS, although the existence of a family history of cataract was only encountered in these patients. This raises the intriguing possibility that lens ferritin accumulation might be a factor contributing to age-related cataract in the general population. Additional causes of isolated hyperferritinemia remain to be identified. 相似文献
67.
Emilie Ronin Charlotte Pouchy Maryam Khosravi Morgane Hilaire Sylvie Grgoire Armanda Casrouge Sahar Kassem David Sleurs Gaëlle H. Martin Nomie Chanson Yannis Lombardi Guilhem Lalle Harald Wajant Cdric Auffray Bruno Lucas Gilles Marodon Yenkel Grinberg-Bleyer Benoît L. Salomon 《Proceedings of the National Academy of Sciences of the United States of America》2021,118(13)
68.
69.
70.
Huong DL Wechsler B Vauthier-Brouzes D Duhaut P Costedoat N Lefebvre G Piette JC 《Seminars in arthritis and rheumatism》2002,32(3):174-188
OBJECTIVE: To analyze the results and complications of ovulation induction therapy (OIT) in women with systemic lupus erythematosus (SLE) and/or the antiphospholipid syndrome (APS). METHODS: A retrospective study of 21 women followed in a single tertiary-referral French center who underwent 114 OIT cycles with or without in vitro fertilization and embryo transfer (IVFET). RESULTS: Before OIT, SLE was present in 6 women, APS in 3, SLE-related APS in 3, and discoid lupus in 1. Eight women had no identified disease and underwent 36 cycles of OIT. Diagnosis (SLE, n = 3; primary APS, n = 5) was made after OIT complication: spontaneous abortion (n = 5), SLE flare (n = 2), and thrombophlebitis (n = 1). Five women with known disease intentionally concealed their history from their gynecologists and underwent 34 cycles. Forty-four cycles were planned in 11 women, in 3 of them after complications of prior OIT performed without particular therapy and monitoring. Eighteen pregnancies occurred, which ended in 9 live births, 4 fetal deaths, and 5 embryonic losses. The pregnancy rate was higher with gonadotropin and/or gonadotropin-releasing hormone analog (GnRHa) (25% of cycles) than with clomiphene (4% of cycles, P <.0001). When the gynecologists did not know the underlying disease, three-quarters of pregnancies induced by OIT with IVFET ended in embryonic losses or fetal deaths. In contrast, 6 of 7 pregnancies induced by planned OIT with IVFET ended in live births (P <.0001). Phlebothromboses were observed only with gonadotropin treatment. The SLE flare rate was higher with gonadotropin and/or GnRHa (27% of cycle) than with clomiphene (6%, NS). It also was higher (30%) when the gynecologists did not know the underlying disease than in the planned procedures (10%, NS). CONCLUSIONS: The OIT may precipitate SLE or APS. A careful review of the patient's history and appropriate laboratory tests should be undertaken before OIT. Clomiphene complications are rare. When gonadotropins are prescribed, preventive anti-inflammatory therapy should be considered in women with SLE, in addition to heparin and/or anti-aggregant therapy in patients with asymptomatic anti-phospholipid antibodies or prior thrombotic events. 相似文献